investorscraft@gmail.com

Intrinsic ValuePerfect Medical Health Management Limited (1830.HK)

Previous CloseHK$1.21
Intrinsic Value
Upside potential
Previous Close
HK$1.21

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Perfect Medical Health Management Limited operates as a specialized provider of non-surgical aesthetic and wellness services across key Asian and Australian markets. The company's core revenue model is built on a high-volume, appointment-based system offering treatments including medical beauty, hair growth, pain management, and preventive care. Operating in the consumer cyclical sector, it capitalizes on growing demand for appearance-enhancement and health-maintenance services among urban populations. Its market positioning is that of an accessible premium provider, leveraging a chain of service centers to achieve economies of scale and brand recognition. The firm distinguishes itself through a integrated service portfolio that combines aesthetic treatments with broader health management, catering to a clientele seeking holistic well-being solutions. This strategic focus on non-invasive procedures allows for repeat customer visits and stable cash flow generation, underpinning its established presence in a competitive and rapidly evolving personal care industry.

Revenue Profitability And Efficiency

The company generated HKD 1.13 billion in revenue with a net income of HKD 206.9 million, reflecting an 18.3% net margin. Strong operating cash flow of HKD 332.9 million significantly exceeded net income, indicating high-quality earnings and efficient cash conversion from its service-based operations, with modest capital expenditure requirements relative to cash generation.

Earnings Power And Capital Efficiency

Diluted EPS stood at HKD 0.16, demonstrating the firm's ability to translate top-line performance into shareholder returns. The substantial operating cash flow highlights robust core earnings power, efficiently funding operations and investments without excessive capital intensity, as evidenced by manageable capex levels.

Balance Sheet And Financial Health

The balance sheet shows a solid liquidity position with HKD 249.1 million in cash against total debt of HKD 216.6 million, indicating a conservative leverage profile. This financial structure provides flexibility for ongoing operations and potential strategic initiatives while maintaining a healthy cushion for uncertainties.

Growth Trends And Dividend Policy

The company maintains a shareholder-friendly approach, distributing a dividend of HKD 0.166 per share. This payout, exceeding the diluted EPS, suggests a commitment to returning capital to investors, potentially supported by strong cash flow generation rather than solely current period earnings.

Valuation And Market Expectations

With a market capitalization of approximately HKD 1.95 billion, the market values the company at roughly 1.7 times revenue and 9.4 times net income. A beta of 0.997 indicates stock performance closely aligned with broader market movements, reflecting typical cyclical consumer sector volatility expectations.

Strategic Advantages And Outlook

The company's strategic advantages include its established brand, diversified service portfolio, and geographic footprint across growing Asian markets. Its asset-light service model and strong cash flow generation provide a solid foundation for sustained operations and potential regional expansion in the competitive aesthetic and wellness services industry.

Sources

Company Annual ReportHong Kong Stock Exchange Filings

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount